Understanding medical device regulations in the Netherlands is essential for manufacturers, importers, authorised representatives and distributors seeking access to the Dutch and wider EU markets. The Netherlands follows EU MDR and IVDR directly but compliance doesn’t stop at CE marking. There are country-specific obligations that sit on top of the EU rules. Getting these right early makes the whole process considerably smoother.
This guide covers what matters most including device classification, CE marking, registration, quality management, import requirements and post-market surveillance helping manufacturers move through the process with clarity and confidence.
Regulatory Authorities for Medical Devices in Netherlands
Under the Dutch Medical Devices Act, the Minister for Medical Care is the designated competent authority for the purposes of MDR Article 101 and IVDR Article 96. Two organisations carry out that mandate in practice, and they do different things.
Health and Youth Care Inspectorate (IGJ) is the Netherlands’ supervisory authority for medical device compliance. It sits within the Ministry of Health, Welfare and Sport but operates independently as a supervisor. IGJ is responsible for monitoring and supervising compliance with medical device requirements, working alongside oversight counterparts in other EU member states.
But day-to-day registration paperwork doesn’t run through IGJ directly. That’s handled by Farmatec, a department of CIBG, an executive agency of the Ministry of Health, Welfare and Sport. Farmatec carries out these registration tasks for the ministry.
People new to the Dutch market often use IGJ and Farmatec interchangeably, but they serve different roles. IGJ is responsible for supervision and enforcement, while Farmatec manages registrations and EUDAMED registration assessments. Farmatec/CIBG also issues export certificates (free sale certificates) to manufacturers registered in the Netherlands.
Beyond Dutch borders, the European Commission oversees MDR/IVDR EU-wide. Responsibility for conformity assessments of higher-risk devices lies with Notified Bodies listed in the NANDO database.
Netherlands Medical Device Classification
Netherlands Medical Device Classification runs entirely on MDR Annex VIII.There is no separate Dutch device classification system. Devices fall into Class I, IIa, IIb, or III, based on invasiveness, duration of body contact and whether the device is active.
- Class I – Lowest risk, generally self-declared
- Class IIa – Low to Moderate risk, Notified Body required
- Class IIb – Moderate to Higher risk, Notified Body required
- Class III – Highest risk, Notified Body required
Class Is (sterile), Class Im (measuring), and Class Ir (reusable surgical instruments) are distinct Class I subtypes that require Notified Body involvement for the relevant aspects of conformity assessment. IVDs also follow their own four-tier system under IVDR, Class A through D.
Borderline cases are where classification becomes challenging. For example, a seemingly minor claim in the labeling, such as a measuring function, can change the applicable classification from Class I to Class Im, triggering Notified Body involvement. Where manufacturers and notified bodies disagree on a classification, or a case proves genuinely difficult, it can be referred to the MDCG’s Borderline and Classification Working Group, which publishes its agreed positions in the Manual on Borderline and Classification.
Authorized Representative (AR) Requirements in Netherlands
Non-EU manufacturers are required to appoint an EU Authorised Representative before placing a device on the market. The AR can be based anywhere within the EU but, in practice, many non-EU manufacturers choose to establish theirs in the Netherlands. The country’s strategic logistics position including the Port of Rotterdam and its well-organised regulatory environment make it a practical and popular choice.
An EU Authorised Representative does more than provide a local address. Under Article 11 of the MDR and IVDR, the AR must verify the Declaration of Conformity, keep technical documentation available for regulators on request, cooperate with competent authorities and act on the manufacturer’s behalf.
A written mandate between the manufacturer and the AR is mandatory and must be effective for at least all devices within the same generic device group.
Medical Device Regulatory Guidelines in Netherlands
The Netherlands has two regulations that govern medical device compliance: MDR (Regulation (EU) 2017/745) and IVDR (Regulation (EU) 2017/746). In addition to these regulations, manufacturers also need to work with the MDCG guidance documents and harmonised standards for the correct application of the requirements in practice.
MDCG guidance is worth paying attention to even though it carries no legal force on its own. IGJ references it during inspections and Notified Bodies use it to frame their assessments so in practice it functions closer to a requirement than a suggestion.
Standards are maintained in the Netherlands through NEN the Netherlands Standardization Institute. ISO 13485 and other harmonized standards referenced in technical documentation should always be the current NEN-adopted versions. It’s a detail that gets overlooked when documentation is carried over from other markets or earlier submissions.
Medical Device Registration Process in Netherlands
To register a medical device in the Netherlands, manufacturers must complete the applicable EU MDR or IVDR conformity assessment and fulfil the Netherlands-specific registration requirements. Below is the typical step-by-step registration process.
Step 1: Classify the Device
Start here, and get it right. Netherlands Medical Device Classification follows MDR Annex VIII rules which are based on intended use, duration of body contact, invasiveness and whether the device is active. Class I is lowest risk; Class III is highest. IVDs follow IVDR and run Class A through D. A wrong classification invalidates the conformity route you’ve chosen and everything built on it.
Step 2: Build Technical Documentation
Technical documentation follows MDR Annex II and III and must cover the device description, design and manufacturing information, a General Safety and Performance Requirements (GSPR) checklist, risk management file per ISO 14971 and a clinical or performance evaluation. This is the backbone of the submission. Everything IGJ or a Notified Body reviews traces back to this file.
The most common documentation problem we see is the internal inconsistency. The intended use described in the clinical evaluation doesn’t quite match what’s on the label, and the risk management file references a third version. Align these before you move forward.
Step 3: Engage a Notified Body (Where Required)
Class IIa, IIb, and III devices, plus sterile and measuring-function Class I devices, need a Notified Body conformity assessment. The Chosen Notified Body should be designated under the NANDO database. Notified Body capacity constraints have been widely reported across Europe, and this step alone can take considerable time depending on device complexity. Manufacturers should plan accordingly.
Step 4: Sign the Declaration of Conformity and Apply CE Marking
Once the conformity route is satisfied, the Declaration of Conformity is signed and the CE mark is applied. For eligible Class I devices this is done through self-certification; for higher classes it follows Notified Body assessment.
The Declaration of Conformity must specify the name of the manufacturer, the device, the relevant regulation and where appropriate the Notified Body and its certificate number. In the Netherlands, CE Marking for medical devices means that the medical device fulfills all applicable EU requirements.
Step 5: Register in EUDAMED
EUDAMED (European Database on Medical Devices) registration is mandatory. Economic operators must register in order to obtain a Single Registration Number (SRN), which is necessary for obtaining a conformity assessment and for placing the device available on the market.
Step 6: National Notification Through Farmatec/NOTIS
This step is often misunderstood by foreign manufacturers. Only custom-made devices must be notified through the Dutch NOTIS system managed by Farmatec, as a standing national requirement under Article 2 of the Ministerial Regulation. Class I devices and IVDs no longer need separate NOTIS notification. Farmatec has confirmed that registering them in the relevant EUDAMED modules satisfies the national requirement and double registration is not necessary.
Once a complete submission is in, processing runs up to 90 days. Incomplete submissions restart that clock.
Teams sometimes treat NOTIS as a catch-all formality after CE marking is done, which can lead to unnecessary duplicate filings for Class I devices and IVDs, or missed filings for custom-made devices. Confirm which category applies before submitting anything.
Step 7: Finalize Dutch-Language Labeling and IFU
Labels and Instructions for Use (IFU) must be in Dutch for devices placed on the Dutch market, alongside the UDI (Unique Device Identifier) and all MDR/IVDR-mandated symbols. Manufacturers must not leave this for after registration because translation and layout review take time and errors here can hold up market access.
Step 8: Place the Device on the Market and Begin PMS
Once the above steps are complete, the device can enter the Dutch market. Post-market surveillance must start immediately. The PMS plan should already be active, feeding complaint data, literature reviews and field feedback into your monitoring system from day one.
Required Documents for Medical Device Registration in Netherlands
The core technical documentation required under MDR Annexes II and III includes:
- Device description and specification
- Design and manufacturing information
- General Safety and Performance Requirements (GSPR) checklist
- Risk management documentation
- Clinical evaluation report (CER) for medical devices or a performance evaluation report (PER) for IVDs
- Post-market surveillance (PMS) documentation
For national registration through Farmatec, manufacturers will also need the Declaration of Conformity, the CE certificate (where a Notified Body was involved) and company identification details.
Manufacturers must ensure the EU Declaration of Conformity includes the manufacturer’s details, the relevant regulation, the device identification and the authorised representative’s information, where applicable.
QMS Requirements for Medical Devices in Netherlands
For standard self-certified Class I devices ISO 13485 certification is generally not required, though Article 10 of MDR still requires manufacturers to maintain an appropriate quality management system.
Article 10 sets out QMS obligations covering risk management, clinical evaluation, document control and post-market surveillance, and these apply to every device class, including Class I. What changes by class is oversight. A Notified Body assesses the QMS for Class IIa and above, while Class I manufacturers self-declare that it meets these requirements. The Netherlands does not add requirements beyond what MDR already mandates on this point.
In practice, IGJ does review QMS implementation during inspections, and gaps between documented procedures and what’s actually happening on the floor are a finding that comes up regularly.
Medical Device Labeling & IFU Requirements in Netherlands
Dutch-language labeling and IFUs are required for the Dutch market, under Article 1 of the Ministerial Decree. There’s an exception. Devices used exclusively by professional users, such as doctors, laboratory staff or nurses, may carry an English-language label and IFU. The manufacturer must ensure adequate English proficiency among users and monitor this through post-market surveillance.
Standardized symbols may be used where permitted, provided they comply with the MDR/IVDR and relevant harmonized standards.
Mandatory label information includes:
- Manufacturer’s name and address.
- Authorised Representative’s details (where applicable).
- Device name or trade name.
- Information needed to identify the device and its contents.
- Lot number or serial number.
- UDI (where applicable).
- Expiry date or use-by date, where relevant.
- Sterile status and sterilization method, where applicable.
- Any special storage or handling conditions.
- Warnings, precautions, or limitations necessary for safe use.
- CE marking, together with the Notified Body identification number where required.
Registration Timelines for Medical Devices in Netherlands
Once a complete submission has been received, NOTIS notifications (now limited mainly to custom-made devices) are processed within a maximum of 90 days. Amendments or deregistration of existing NOTIS entries not yet migrated to EUDAMED are processed within a maximum of 3 months.
These EUDAMED registration deadlines apply across all device classes: devices placed on the market on or after 28 May 2026 must be registered in EUDAMED before the first unit is placed on the market, while devices already on the market before that date must complete registration by 28 November 2026.
Class I devices: Standard Class I devices can be placed on the market once the manufacturer has met the applicable MDR requirements and completed EUDAMED registration. Separate NOTIS notification is not required for standard Class I devices.
Class Is, Class Im, Class Ir, Class IIa, IIb, and III devices: Timelines depend on the Notified Body’s conformity assessment. Notified Body capacity constraints have been widely reported across Europe, and this step alone can take considerable time depending on device complexity.
Once registered, economic operators must reconfirm the accuracy of their EUDAMED data within one year of initial submission and every two years thereafter. Failing to do so within six months of that deadline can trigger corrective measures by a Member State.
Medical Device Registration Costs in Netherlands
Farmatec publishes specific fees for its own services: €200 per product for a notification, €62 plus €62 quarterly administration costs for an export declaration and no charge for amendments. IGJ does not publish a comparable fee schedule for inspections or supervisory activity aimed at manufacturers, as its role is statutory oversight rather than fee-for-service. Notified Body conformity assessment fees are set independently by each Notified Body.
Class I self-certification involves internal documentation costs and possibly translation/labeling spend, with no Notified Body fee. Higher classes carry Notified Body assessment fees, which vary by device type and the specific NB manufacturers choose.
AR fees, if applicable, are a separate ongoing cost agreed contractually.
Import Requirements for Medical Devices in Netherlands
Importing medical devices into the Netherlands requires compliance with both Dutch customs procedures and the applicable EU medical device regulations.The customs clearance process is managed by Dutch Customs (Belastingdienst).
Importers have specific responsibilities under the MDR and IVDR. These include verifying the CE marking, ensuring compliance of the labeling and instructions for use and verifying that the manufacturer and the device are properly identified before the device is placed on the market. Where applicable, they must also confirm that the manufacturer has appointed an EU Authorised Representative.
Non-EU manufacturers must also ensure the device is placed on the market through an EU-based importer.
Post-Market Surveillance Requirements in Netherlands
Once a device is on the market in the Netherlands, the compliance work continues under a structured post-market surveillance (PMS) system required by MDR. The process begins with a Post-Market Surveillance Plan (PMSP). A documented strategy outlining what data you’ll collect, from which sources, and how often.
The reporting requirements then depend on the device classification. Manufacturers of Class I devices must prepare a Post-Market Surveillance Report (PMSR) in accordance with Article 85.
The reporting requirements become more extensive for higher-risk devices. Under Article 86, manufacturers of Class IIa, IIb, and III devices must prepare a Periodic Safety Update Report (PSUR). The report is updated as needed, and at least every two years for Class IIa devices, and at least annually for Class IIb and Class III devices.
For Class III and implantable devices, the PSUR must be submitted to the Notified Body and a Summary of Safety and Clinical Performance (SSCP) must be validated by the Notified Body. Both are designated to run through EUDAMED’s Vigilance and Post-Market Surveillance module, but the European Commission currently lists this module as still under development, so in practice this exchange runs through the Notified Body’s own established channel rather than EUDAMED itself.
Manufacturers may also need to conduct Post-Market Clinical Follow-up (PMCF) to collect real-world clinical data and support ongoing updates to the Clinical Evaluation Report (CER). In addition to routine post-market surveillance, manufacturers must report serious incidents and Field Safety Corrective Actions (FSCAs) to the competent authority within the applicable reporting deadlines. Trend reporting is also required when a statistically significant increase in non-serious incidents or expected undesirable side effects could affect the device’s benefit-risk profile.
Conclusion
Most delays in Netherlands medical device registration come down to the same handful of issues like wrong classification, weak AR setup, missed national registration or PMS documentation that exists on paper but doesn’t hold up in practice. None of these are complicated to fix when caught early.
With Artixio’s end-to-end medical device registration services, manufacturers can streamline market entry and stay compliant throughout the product lifecycle. Reach out to us at info@artixio.com for guidance tailored to your device and market entry goals.
FAQs
Q1. Is CE Marking for Medical Devices in the Netherlands enough on its own to sell the device?
No. CE marking under MDR/IVDR is necessary, but it isn’t sufficient on its own. Nearly all devices also need EUDAMED actor and device registration, and custom-made devices additionally require registration through Farmatec/NOTIS.
Q2. Does every device need a Notified Body?
No. Self-certified Class I devices without a measuring function, sterility claim, or reusable-surgical-instrument classification generally don’t, but most other classes do.
Q3. What language must labeling and IFUs be in?
Dutch, alongside whatever symbols and identifiers MDR/IVDR mandate. An exception applies to devices used exclusively by professional users, which may use English instead, under Article 1(2) of the Ministerial Regulation.
Q4. Can a non-EU manufacturer register directly with Farmatec?
Generally no. This is handled through an EU Authorized Representative established in the Netherlands or another member state.
